🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Nomifensine

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nomifensine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

fluoxetine
3 shared targets
sibutramine
3 shared targets
mazindol
3 shared targets
dextroamphetamine
3 shared targets
difluorobenztropine
3 shared targets
vanoxerine
3 shared targets
amitifadine
3 shared targets
vilazodone
3 shared targets
atomoxetine
3 shared targets
bupropion
3 shared targets
Loading evidence profile...

This evidence profile for Nomifensine is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.